chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt experienced dizziness, tunnel vision, blurred vision, felt like she was going to pass out. Pt moved to stretcher and laid flat for 5 minutes. Given juice and crackers at 10 minutes post vaccine. Pt states she is feeling better, color improved, eating snack and VSS. 1802:  106/56  75  12  100% pulse ox 1810:  114/65  65  12  100% pulse ox 1830:  139/56  74  12 100% pulse ox   Pt observed additional 45 minutes and released to care of friend to return home.
Pt received COVID vaccine on 11/17/22 @ 4:30 pm. Started with hives all over body on that evening. Improved with Benedryl.
After 3 days 1st dose loose hearing then went to ER. They told me ears was clear no fluid given steroids' to take. I went Hearing specialist was told by doctor I have 80% right hearing loss.
Red, mottled area left upper arm about 15 cm x 15 cm. Instructed to take Benadryl daily.
Pt stated on 27NOV91 exp "hives & itching" @ thigh, arms, & inject site p/previous rabies vax recvd on 21NOV91; Pt did not seek medical attention;
This spontaneous report as received from a pharmacist (R.Ph) via a company representative refers to 3 patients of unknown age and gender. On an unknown date of year 2012 the patients were vaccinated with a dose of ZOSTAVAX (dose, route and lot # not provided). Concomitant medication was not reported. On an unknown date the patient experienced rash, after receiving ZOSTAVAX, described as worse than normal, in comparison to flu vaccine over the past year. The outcome of rash was unknown. Patient was advised to contact pharmacist if rash worsened; however there was no further contact from the three patients. No identifying patient information was provided. VZVIP packet was faxed. This is one several cases reporting from same source.  Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm that was vaccinated, in the "upper muscle area"), PAIN (has severe pain if she is touched/really hurts to raise her arm), ARTHRALGIA (pain radiates to shoulder) and ARTHRALGIA (pain radiates to elbow) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 16-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm that was vaccinated, in the "upper muscle area"), PAIN (has severe pain if she is touched/really hurts to raise her arm), ARTHRALGIA (pain radiates to shoulder) and ARTHRALGIA (pain radiates to elbow). At the time of the report, PAIN IN EXTREMITY (pain in the arm that was vaccinated, in the "upper muscle area"), PAIN (has severe pain if she is touched/really hurts to raise her arm), ARTHRALGIA (pain radiates to shoulder) and ARTHRALGIA (pain radiates to elbow) outcome was unknown. Not Provided          Treatment was unknown.  Upon in internal review on 21 May 2021, the age was corrected to an unknown age.   Reporter did not allow further contact
Pt recvd vax 27MAY92 & 19JUN92 pt exp chest pain, chest heaviness, wall of pain come up the anterior chest, sharp, into neck, quesy, esophageal reflux, burning feeling in chest/epigastric area; edema of ankles; ulcer disease, gastritis;
pt did not have any symptoms or adverse effects of receiving vaccine; administration of vaccine following temperature excursion; This spontaneous report was received from a medical assistant and refers to a specified patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent (manufacturer unknown).   On 08-APR-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter/once, lot # U024221, expiration date: 04-AUG-2023, administered for prophylaxis (strength, anatomical location and route of administration were not provided). Prior to being administered, the vaccine underwent a temperature excursion of -13 degrees Celsius for 1 hour (product storage error). Patient did not have any symptoms or adverse effects of receiving the vaccine (no adverse event).
Information has been received from a licensed practical nurse, for HPV rL1 6 11 16 18, a Pregnancy Registry product, concerning a 20 year old female with no drug reaction and with a LMP of late April who on 02-APR-2012 was vaccinated intramuscularly with the first dose of HPV rL1 6 11 16 18 (lot # 672193/1524AA, Exp Date 23-AUG-2014). On 672233/1561AA, Exp Date 26-AUG-2014). There was no concomitant medication. The patient sought medical attention by office visiting. There was no lab diagnostics studies performed. All telephone attempts to obtain follow-up information have been unsuccessful. This case is lost to follow up and pregnancy outcome is to be considered lost to follow up. Additional information is not expected.
mild symptoms; Loosing hairs of head; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (mild symptoms) and ALOPECIA (Loosing hairs of head) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 07M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced ALOPECIA (Loosing hairs of head). On an unknown date, the patient experienced ADVERSE EVENT (mild symptoms). At the time of the report, ADVERSE EVENT (mild symptoms) and ALOPECIA (Loosing hairs of head) outcome was unknown.            Concomitant medications include thyroid, blood pressure and blood thinner medicine. Reporter did not provide any treatment medications.
Brought to office 1 day after receiving PEDIARIX with bulging fontanel & low grade fever 99.7 (ax) sent to ER for spinal tap, which was negative.
78 year old female presenting with acute onset of L sided hemiparesis, left facial droop, and aphasia at 1340 on 12/6 found to have acute right MCA occlusion requiring thrombectomy s/p Tpa administration. Pt in acute respiratory failure requiring emergent intubation in the ED prior to procedure. Post operatively pt with continued poor neurologic exam as well as hypoxia and hypotension.  through workup pt found to have diffuse arterial and venous thrombosis, including L PE and L femoral and popliteal DVTs. Acute DIC  s/p multiple blood transfusions accompanied by multi system organ failure. Ultimately pt passed away 12/7 1150.
2nd dose was given too early.  Pt  should have received on December 20th and it was given on December 14th, 2021.
Red rash around injection site about 5 inches developed on 2/3 One week prior on 1/27 at 6:30 pm developed very painful upper back. Topical cream and OTC med not helpful. Gone by the next morning
Headache started about 3 hours after injection, 4 regular Advil didn't help me feel better and it persisted all night and into the morning. By 8 am 29th October its better but not completely resolved.
tachycardia to 170, orthostatic hypotension, chest pain, SOB, headache, seizure like episode.  Over 1 month progressed to demylinating disease with loss ability to ambulate, use hands c/w Guillian-Barre Syndrome; autonomic dystonia; recurrent non-epileptic seizure like events.
tingling like pins and needles in her feet; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling like pins and needles in her feet) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Menopause (takes hormone replacement therapy twice a week.) and Panic attacks. Concomitant products included ALPRAZOLAM (XANAX) for Panic attacks.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced PARAESTHESIA (tingling like pins and needles in her feet). At the time of the report, PARAESTHESIA (tingling like pins and needles in her feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.  Patient said that it turns out side effects and needed back surgery.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow up received on 19 Jul 2021 contains non-significant information
This spontaneous case, initially received from other non-health professional on 14-Nov-2018, concerning a female patient of unspecified age. On an unspecified date, the FLUCELVAX QIVc vaccine underwent first temperature excursion with Tmax 8.2 degree centigrade for 4 minutes. On 22-Oct-2018, vaccine underwent second temperature excursion with Tmax 9.8 degree centigrade for 23 minutes. On an unspecified date, two temperature excursions were identified after an audit. On 25-Oct-2018, the patient was inadvertently administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 252672 and expiry date: 30-Jun-2019) which underwent temperature excursion. The patient did not experience any adverse events after administration. This case is linked to (201805262) due to same reporter.
Said he rec'd the flu shot yesterday. At supper he vomited. At 6P he developed chills, put a sweater on. At bedtime he felt hot, did not take temp. He developed all over joint achiness. At 3A he woke, could not go back to sleep. Denies any urinary sx. States sx have gone completely away, is back to baseline at present wants to know if sx could be caused by flu shot.
12 yo in for 12+ BV Booster mistakenly given 5-11 BV Booster. Primary onsite staff marked 12+ BVB record as false and created this 5-11 BV Booster appt for child. Nurse logged this record in order to accurately report dose given. New appt for 12+ BV Booster scheduled for December 3rd per parent's instruction.
Erythema, pain at injection site, headache, nausea ongoing for 3 days.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 19-AUG-2013, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J000141 and expiry date: 04-JUL-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Janssen COVID-19 Vaccine EUA. Body ache until the following morning (4/8/2021) around 12pm. Chills started around 7pm on 4/7/2021 and also subsided around 12pm on 4/8/2021. I took one Pamprin, from symptom onset, every 6 hours with the last dose at 5:45am on 4/8/2021.
Breakthrough menstrual bleeding when I wasn't supposed to have my period; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA Vaccine; Lot number EN6204), via an unspecified route of administration in the left arm on 21Mar2021 at 14:45 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included depression and GERD (as reported). The patient received unspecified medications within 2 weeks of vaccination. The patient previously received penicillin (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the vaccination. On 23Mar2021, the patient experienced breakthrough menstrual bleeding when it wasn't supposed to have the period. The patient did not receive any treatment medication for adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The clinical outcome of the event menstrual bleeding was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Adverse event: inadvertently administered expired Hep A vaccine. APRN inadvertently administered an expired vaccine to her patient because she failed to verify the expiration date on the vaccine vial before administration. Patient was monitored for 15 minutes after administration and did not experiences any adverse reactions to vaccine.
Fever, chills, muscle aches, lethargy, diarrhea, stomach cramps
*I felt fine except for an uncomfortable slight PAIN IN MY HEART within 10 minutes after the shot. I was able to drive home and function normally.  Ever since then, every day for a few moments I feel uneasy around my heart area, but my pulse seems normal (resting heart rate 62 beats per minute).     * I had a sore arm for 3 days after the short meaning bad muscle cramps in my left arm.  I was able to function, but it felt like I worked out in a gym and had cramps so badly it hurt to raise the arm.  I did not see this as an emergency and the soreness went away after a few days (but the slight uneasiness in the heart area remained).   * The evening / night of the vaccine shot I felt a little tiny bit of nausea, but I was able to eat and function perfectly fine.
The day following a third full dose of the Moderna vaccine severe fatigue, chills, and body aches that lasted 2 days. Normal adverse events resolved over the next 2 days. Within a week a severe dry cough developed along with a flare of the formerly resolved paradoxical psoriasis.   As the cough worsened and chest pain developed, I was treated with a course of azithromycin, albuterol inhaler, and cough suppressants.  When this still failed to reduce the cough, I was prescribed inhaled budesonide and refered to a pulmonologist. Breathing function tests indicated normal lung function but improved function after albuterol. X-rays showed bilateral patches and a chest CT and blood work was ordered.  Blood work showed no signs of bacterial infection. There were markers for inflammation and autoimmune disease. Based on the chest CT, the radiologist diagnosed organizing pneumonia. The pulmonologist agreed with the diagnosis and since the cough was slowly improving, recommended fluticasone furoate and a follow-up in mid January 2022. As of January 3rd the cough persists but is less severe than in October 2021.
Chief Complaint: Covid like Symptoms.  Pt complains of vomiting, nausea, diarrhea, mild cough, SOB, rhinorrhea and fever.Treated with IV antibiotics, remdesivir, steroids vit c, vit d, zinc OptiFlow.  home with oxygen
On June 6, 1999, the patient developed breakthrough case of varicella that consisted of twenty or fewer lesions. It was noted that this was a mild case, however it required a visit to MD.
Breaking out in hives in random areas ever since 5/17.  This is not typical for my medical history.  Continues to occur daily one week after shot.
I started having mild chest pains, heart pounding, and shortness of breath the day following receiving the COVID booster shot (pFizer, originally got the J&J COVID shot in April 2021). The chest pain was pretty mild most of the time, more of a discomfort (1 out of 10), but would swell in intensity. At its most intense, it was still a mild pain (maybe 4 out of 10). The pain was on my left side of my chest, but moved around, sometimes being in front close to my nipple, and other times being on the side closer to my armpit.   Worried about vaccine side effects, I called my primary care facility 2 days following getting the vaccine (10/26) to get a tele-visit, but ended up speaking to a nurse without having an actual visit. Nurse didn't feel it was anything needing care at the moment due to the low level of pain and because I mentioned I've also felt a low level of anxiety for months (shortness of breath, heart pounding/fast heart beat), but advised if the pain got worse to go to an urgent care facility.   I monitor my blood pressure at home regularly, and my BP was in its normal range. 118/78.   The pain went away around 5 days after receiving the COVID vaccine booster.
PATIENT UNDER 18 RECEIVED MODERNA, WHICH IS ONLY INDICATED FOR 18 AND OLDER. PATIENT DID NOT HAVE ANY ADVERSE REACTION.
Case previously recorded as MA2009-4554.  Initial case report received from a nurse via agency on 18 NOV 2009.  A 57-week old male patient was accidentally vaccinated with 0.5 mL i.m. FLUVIRIN 2009/2010 (batch no. 102126P1A) on 17 NOV 2009.  It was an out off label use because the patient was younger than 4 years.  No adverse events were reported.  Off label use is unexpected after vaccination with FLUVIRIN 2009/2010.  No change in benefit-risk-ratio.  No measures are necessary.  Agency reference no.: NA09-008426.
Tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for covid) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Sep-2021, the patient experienced COVID-19 (Tested positive for covid). At the time of the report, COVID-19 (Tested positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.         No concomitant medication details were provided.  No treatment medication details were provided.
itches; arm swollen; Red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itches), VACCINATION SITE SWELLING (arm swollen) and VACCINATION SITE ERYTHEMA (Red) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itches), VACCINATION SITE SWELLING (arm swollen) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, VACCINATION SITE PRURITUS (itches), VACCINATION SITE SWELLING (arm swollen) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
at injection site, Black & Blue- Redness 1/4 of way to elbow
Received J&J in May. Took the moderna booster on 10/25. Woke up to chest pain that worsens with deep breaths
Pneumovax L arm became red, pruritic, swollen within 24 hrs of vacc.
PATIENT EXPERIECING REDNESS AROUND INJECTION SITE. REDNESS WARM TO THE TOUCH. CURRENTLY NO PAIN AND NOT GROWING. PT WAS CONCERNED AND CAME INTO THE PHARMACY FOR US TO LOOK AT. PATIENTS PRIMARY MD WILL BE FOLLOWING UP WITH HER.
Headache, Myalgia, head fogginess, fatigue weakness, unsteady gait  Narrative: N/A
Vaccine administration error - vaccine administered was 2 days past its month-long refrigeration beyond use date. Manufacturer was contacted who said that research showed sustained efficacy for 45 days refrigeration off-label, but could not provide guidance for re-vaccination. Patient was contacted with the option to re-vaccinate.
Severe left ear pain, Shingles in left ear, Left side facial paralysis, dizziness.
Shoulder injury resulting from vaccination administration (SIRVA)  The pharmacist administering the vaccination had a difficult time and took an exceptionally long time to deliver the vaccine. Within a few hours, the pain in my left upper arm and shoulder was so severe that I could not lift my arm at all. I reported it to the pharmacist on duty that evening.  She was familiar with the problem and told the woman who gave me the shot about my reaction.  Although the pain lessened to some degree, on October 22, 2020 I had an appointment with my physician to discuss the continuing problem.  Five months after vaccination, the pain finally stopped.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a adult patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX, at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. The health care professional reported that two people had pain at the injection site for 24 hours after a SHINGRIX vaccination. The patient or vaccine information was not collected during chat. This case was linked with case US2018079508, reported by the same reporter.
Severely sore arm, fever, headache, back ache low sacral area for 8 days, nausea weakness
07/05/07-4 hrs. after IZ, malaise/achiness.  By later that evening states had stomach cramps, diarrhea, nausea/vomitting, temp (as high as 103.8 F).  07/07/07-Was given 2 liters IV fluid at home by an RN the patient knew (no MD or ER visit). 07/09/07-Called Health Dept. to report symptoms. Temp 100.4 @present. States queasiness, mild diarrhea, malaise today. No vomitting. Clear fluids encouraged with easy to digest foods. Instructed to visit doctor or ER if symptoms persist or get worse. 07/16/07-Called for F/U today. States feels better. States had lingering headaches since illness but not today. Has not visited doctor.
Around  May  2021,  I?ve been having intermittent lt arm pain around the location of the shot area.  NEVER BELOW THE LT ELBOW  OR AT THE LT ELBOW.  Experience approx  3 times.  It fades w/in 30min.  Also, had swollen lymph nodes  but in RT armpit area in May  2021 too.  Schedule appt. w/my primary doctor.   Appt date in June.  :(.   Swelling went away 1-2  days later.   Hasn?t returned.  Little worried due to having had breast cancer- rt breast.  Just thought you should be aware.  Haven?t had any arm pain in June- yet.
Client in clinic today states that a slight rash appeared on his arms, legs and upper body on 1-17-13. States that it itches really bad, but on SOB or any other problems. States that he has been putting calamine lotion no for the itching, informed client to seek medical help if any s/s of SOB noted or if rash get any worse. Client states that rash seem to be better today.
Pain, redness, swelling at injection site Muscle pain, tiredness, headache, shivering, fever, upset stomach, no appetite for 2 weeks.
17CM X 17CM CELLULITIS TO RIGHT ARM. RIGHT ARM REDNESS AND WARM TO THE TOUCH.